Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06188793 · ClinicalTrials.gov registry record · NA

Virtual Reality (VR) -Directed Brain Gut Behavioral Treatment (BGBT) for Inflammatory Bowel Disease (IBD) Inpatients

A NA study of Inflammatory Bowel Diseases, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06188793 is a NA study of Inflammatory Bowel Diseases that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 40 participants, below the 42,261-participant average among 48 other Inflammatory Bowel Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06188793, a NA study of Inflammatory Bowel Diseases, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The research is studying virtual reality (VR)-directed brain-gut behavioral therapy (BGBT) as a pain treatment option for hospitalized patients with inflammatory bowel disease (IBD). This study is being done to learn if VR-directed BGBT is feasible and acceptable for patients with IBD in addressing pain in the hospital setting. The study hypothesizes that: * At least 75% of enrolled participants will complete the VR-directed BGBT inpatient program * Hospitalized patients with IBD will find VR-directed BGBT acceptable as a pain treatment option in the inpatient setting.

Interventions

  • DEVICE Virtual reality-directed BGBT

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-02-13
Est. Completion 2026-05
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT06188793

The ClinicalTrials.gov registry entry for NCT06188793 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 42,261-participant average among 48 other Inflammatory Bowel Diseases trials with a reported enrollment target (100% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Inflammatory Bowel Diseases appearing as the primary indexed condition, and to 1 intervention - of which Virtual reality-directed BGBT is the first listed.

NCT06188793 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT06188793 about?

NCT06188793 is a clinical study titled "Virtual Reality (VR) -Directed Brain Gut Behavioral Treatment (BGBT) for Inflammatory Bowel Disease (IBD) Inpatients". The research is studying virtual reality (VR)-directed brain-gut behavioral therapy (BGBT) as a pain treatment option for hospitalized patients with inflammatory bowel disease (IBD). This study is being done to learn if VR-directed BGBT is feasible and acceptable for patients with IBD in addressing ...

What is the current status of trial NCT06188793?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-02-13. Estimated completion is 2026-05.

What conditions does trial NCT06188793 study?

This clinical trial studies the following conditions: Inflammatory Bowel Diseases.

What interventions are being tested in trial NCT06188793?

The interventions under investigation include: Virtual reality-directed BGBT (DEVICE).

Who is sponsoring clinical trial NCT06188793?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06188793 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Inflammatory Bowel Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.